News

Find News

Filter articles

Showing 71 to 80 of 3418 results

Class-action accuses Takeda of ‘pay-for-delay’ deal with Par

US01-07-2021Alex Baldwin

Takeda Pharmaceuticals organised a pay-for-delay deal with Par Pharmaceuticals to prevent a generic version of its constipation treatment from releasing, according to a complaint submitted to the US District Court for the District of Massachusetts.

Breaking: SCOTUS says inventors can challenge their patents, but imposes limits

29-06-2021Muireann Bolger

The US Supreme Court has upheld the doctrine of assignor estoppel in a dispute between Minerva and Hologic but has narrowed its scope.

Novartis wants to claw back $209m in ‘overpayments’ to Genentech

US29-06-2021Alex Baldwin

Roche subsidiary Genentech received $209.5 million in unnecessary payments from Novartis Pharma for a patent licensing deal and is now refusing to return the payment, the Swiss pharma giant has alleged in a redacted complaint.

What China’s new patent laws mean for life sciences

China29-06-2021Alex Baldwin

On June 1, 2021, the Chinese government implemented crucial changes to its patent laws, hoping to create better protections for national and international inventors.

Flatwing fails to shift attorney fees to Pfizer unit, Anacor

US29-06-2021Muireann Bolger

Generic drug maker Flatwing Pharmaceuticals has lost its bid to offset nearly $690,000 in fees and expenses to Pfizer unit Anacor Pharmaceuticals after a US federal judge ruled that the “circumstances were not exceptional” enough to warrant the shift.

Barnes & Thornburg opens Boston office with new partners

US24-06-2021Muireann Bolger

Law firm Barnes & Thornburg has announced the opening of a Boston office, its twentieth in the US, with six partners.

English High Court strikes out bad faith ‘Revolax’ TM

UK24-06-2021Rory O'Neill

A Warrington-based distributor of aesthetic and cosmetic products has lost its UK trademark for a dermal filler brand after the English High Court found it to have registered the brand in bad faith.

SPCs outlive patent protections in 91% of cases, new report reveals

UK24-06-2021Muireann Bolger

Supplementary protection certificates outlive medicinal patents in more than nine in ten cases, a new report has found.

Pharma company fails to block €140m licence payment

US23-06-2021Alex Baldwin

Taiwanese pharmaceutical company PharmaEssentia Corporation has failed to convince a district court judge to throw out a €140 million award to AOP Orphan Pharmaceuticals.

LSPN Connect: The battle for COVID-19 vaccines

International22-06-2021Alex Baldwin

With the COVID-19 vaccines developed, we are now faced with the monumental task of distributing hundreds of millions of vaccines across the globe.

Showing 71 to 80 of 3418 results

LSIPR